Analysis of patient-dependent predictors of residual lesion after cervical conization




conization, epithelial lesions, residual disease, analysis of risk factors


Introduction: in the care of women with precursor lesions of cervical cancer, preventing possible progression to invasive cancer without over-treating the high chances of regression is extremely important. Over time, different treatments and protocols have been tested in order to obtain the best results in the control of this condition with conservative techniques.
Objective: to identify predictors of residual disease depending on the intrinsic characteristics of the patients with conization, due to high-grade epithelial lesions or with microinvasion.
Methods: A prospective descriptive study was conducted to determine the relationship between the diagnosis of residual disease and clinical- epidemiological variables dependent on the patient, in 1090 patients with high-grade cervical epithelial lesions who were treated at the "Héroes del Baire" General Teaching Hospital on the Isle of Youth (Cuba) during the period 2014-2019.
Result: a linear trend of the association of age and residual disease was observed, as well as an association with glandular disease, histological severity and infection by oncogenic serotypes of the human papillomavirus. HPV infection (OR=11.3), history of previous lesion (OR=9.8), persistence of viral infection (OR=4.9) and glandular involvement (OR=3.1) were the factors that showed the greatest association with residual disease.
Conclusion: the severity and size of the lesion, the glandular extension and the persistent infection by the human papilloma virus were the predictive factors that contribute to the existence of residual lesion.


Metrics Loading ...


Ministerio de Salud Pública de Cuba. Programa Integral para el Control del Cáncer en Cuba. Consenso de Radiocirugía del Tracto Genital Inferior. Editorial Ciencias Médicas. La Habana; 2011.

Pierce J, Bright S. Performance of a Colposcopic Examination, a Loop Electrosurgical Procedure, and Cryotherapy of the Cervix. Obstet Gynecol Clin N Am 2013; 40: 731–57.

Fokom Domgue J, Schmeler K. Conservative management of cervical cancer: Current status and obstetrical implications. Best Practice & Research Clinical Obstetrics and Gynaecology 2019; 55: 79-92.

Moradel MA, Crespin MA, Aguilar O. Conización del cuello uterino en patología cervical. Rev Med Hond. 1992; 60: 163-6.

Cui Y, Sangi Haghpeykar H, Patsner B, Bump J, Williams Brown M, Binder G, et al. Prognostic value of endocervical sampling following loop excision of high grade intraepithelial neoplasia. Gynecologic Oncology 2017; 144: 547–52.

Buskwofie A, David-West G, Clare CA. A Review of Cervical Cancer: Incidence and Disparities. Journal of the National Medical Association.2020; 112(2):129-32.

Verguts J, Bronselaer B, Donders G, Arbyn M, Van Eldere J, Drijkoningen M, et al. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation. BJOG. 2006;113:1303–7.

Park JY, Lee SM, Yoo CW, Kang S, Park SY, Seo SS. Risk factors predicting residual

disease in subsequent hysterectomy following conization for cervical intraepithelial neoplasia (CIN) III and microinvasive cervical cancer. Gynecologic Oncology. 2007;107:39–44.

Ayhan A, Aykut Tuncer H, Haberal Reyhan N, Kuscu E, Dursun P. Risk factors for residual disease after cervical conization in patients with cervical intraepithelial neoplasia grades 2 and 3 and positive surgical margins. European Journal of Obstetrics & Gynecology and Reproductive Biology. 2016;201:1–6.

Leguevaque P. Predictors of recurrence in high-grade cervical lesions and a plan of management. Eur J Surg Oncol. 2010;36(11):1073-9.

Morales Fontaine A, Peña Pérez O, Yabor Palomo A, Alvarez Yabor V. Identificación del genotipo del virus del papiloma humano en pacientes portadoras de lesiones cérvicouterinas. Revista Electrónica Dr. Zoilo E. Marinello Vidaurreta. 2016;41(2).

Ramos Triviño R. Factores predictores de enfermedad residual en pacientes con lesión escamosa intraepitelial de alto grado tratadas mediante conización con asa de diatermia. [Tesis doctoral en internet]. Universidad de Alcalá de Henares; 2014;176.

Wise LA, Willis SK, Perkins RB. A prospective study of treatments for cervical intraepithelial neoplasia and fecundability. Am J Obstet Gynecol 2019; 223: 96-110.

Zhu M, He Y, Baak J, Zhou X, Qu Y, Sui L, et al. Factors that influence persistence or recurrence of high-grade squamous intraepithelial lesion with positive margins after the loop electrosurgical excision procedure: a retrospective study. BMC Cancer 2015; 15: 744.

Espín Falcón Julio César, Cardona Almeida Adriana, Acosta Gómez Yuxini, Valdés Mora Mariela, Olano Rivera Mayleni. Acerca del cáncer cervicouterino como un importante problema de salud pública. Rev Cubana Med Gen Integr. 2012;28(4):735-746.

Cordero Martínez J, García Pimentel M. Citologías alteradas y diferentes factores de riesgo para el cáncer cérvicouterino. Revista Ciencias Médicas La Habana, 2015;21(2).

Pirtea L, Grigora D, Matusz P, Pirtea M, Moleriu L, Tudor M, et al. Human Papilloma Virus Persistence after Cone Excision in Women with Cervical High Grade Squamous Intraepithelial Lesion: A Prospective Study. Canadian Journal of Infectious Diseases and Medical Microbiology 2016.

Perez Guzman PN, Chung MH, De Vuyst H, Dalal S, Mutai K, Muthoni L, et al. The impact of scaling up cervicalcancer screening and treatmentservices among women living with HIV in Kenya: a modellingstudy. BMJ Global Health2020;5:e001886. doi:10.1136/bmjgh-2019-001886.



How to Cite

Dávila Gómez HL, Lorie Sierra LE, Díaz-Perera Fernández G, Bacallao Gallestey J, Regalado Rodríguez E. Analysis of patient-dependent predictors of residual lesion after cervical conization. Data and Metadata [Internet]. 2023 Jun. 2 [cited 2023 Dec. 3];2:48. Available from: